PharmaResources Overview
- Year Founded
-
2007
- Status
-
Public
- Employees
-
1,155
- Stock Symbol
-
301230
- Investments
-
1
- Share Price
-
$3.54
- (As of Friday Closing)
PharmaResources General Information
Description
Pharma Resources (Shanghai) Co Ltd is engaged in the drug discovery, research, and development of pharmaceutical processes, and commercial production of API intermediates.
Contact Information
Website
www.pharmaresources.cnCorporate Office
- Building 7, Number 509, Renqing Road
- Pudong
- Shanghai, 201201
- China
Corporate Office
- Building 7, Number 509, Renqing Road
- Pudong
- Shanghai, 201201
- China
PharmaResources Stock Performance
As of 20-Nov-2026, PharmaResources’s stock price is $3.54. Its current market cap is $641M with 181M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.54 | $3.80 | $3.16 - $7.49 | $641M | 181M | 18.9M | $0.02 |
PharmaResources Financials Summary
As of 30-Sep-2026, PharmaResources has a trailing 12-month revenue of $105M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,018,102 | 577,697 | 464,129 | 490,139 |
| Revenue | 105,147 | 95,720 | 75,880 | 69,219 |
| EBITDA | 4,504 | 12,040 | 8,188 | 10,209 |
| Net Income | 4,149 | 4,769 | 2,381 | 5,317 |
| Total Assets | 191,933 | 187,817 | 180,330 | 209,797 |
| Total Debt | 21,512 | 23,627 | 24,891 | 29,111 |
PharmaResources Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
PharmaResources Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
PharmaResources Patents
PharmaResources Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12338255-B2 | Bicyclic substituted sulfonylurea compounds as inhibitors of interleukin-1 activity | Active | 21-Feb-2022 | ||
| US-20230279026-A1 | Novel bicyclic substituted sulfonylurea compounds as inhibitors of interleukin-1 activity | Active | 21-Feb-2022 | ||
| US-20250230140-A1 | Novel triazole-pyridine substituted pyrrolidinyl and tetrahydro-2h-pyranyl acetic acid compounds as lpa antagonists | Pending | 30-Apr-2021 | ||
| US-11040036-B2 | Pyruvate kinase activators for use in treating blood disorders | Active | 18-May-2018 | ||
| US-11364240-B2 | Pyruvate kinase activators for use in treating blood disorders | Active | 18-May-2018 | C07D513/14 |
PharmaResources Signals
PharmaResources Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
PharmaResources Investments (1)
PharmaResources’s most recent deal was a Early Stage VC with BioMeta (Shanghai). The deal was made on 18-Sep-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| BioMeta (Shanghai) | 18-Sep-2024 | Early Stage VC | Drug Discovery |
PharmaResources ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Commercial Services
Industry
Rank
Percentile
Business Support Services
Subindustry
Rank
Percentile
PharmaResources FAQs
-
When was PharmaResources founded?
PharmaResources was founded in 2007.
-
Where is PharmaResources headquartered?
PharmaResources is headquartered in Shanghai, China.
-
What is the size of PharmaResources?
PharmaResources has 1,155 total employees.
-
What industry is PharmaResources in?
PharmaResources’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is PharmaResources a private or public company?
PharmaResources is a Public company.
-
What is PharmaResources’s stock symbol?
The ticker symbol for PharmaResources is 301230.
-
What is the current stock price of PharmaResources?
As of 20-Nov-2026 the stock price of PharmaResources is $3.54.
-
What is the current market cap of PharmaResources?
The current market capitalization of PharmaResources is $641M.
-
What is PharmaResources’s current revenue?
The trailing twelve month revenue for PharmaResources is $105M.
-
What is PharmaResources’s annual earnings per share (EPS)?
PharmaResources’s EPS for 12 months was $0.02.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process